Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Muscle Atrophy clinical trials
Every US clinical trial registered for Muscle Atrophy — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
12 US clinical trials · 7 currently recruiting
The research picture
Muscle Atrophy has 12 registered US clinical trials, 7 of them open to new participants right now — about 58% of the total.
- 7
- recruiting participants now
- 58%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Tufts Medical Center
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
Tufts Medical Center
NCT05627440
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Tufts Medical Center
NCT06253104
Essential Amino Acid Supplementation for Femoral Fragility Fractures
Michael C Willey
NCT06050668
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
AdventHealth Translational Research Institute
NCT03761446
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
University of Maryland, Baltimore
NCT03201094
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
Immunis
NCT05211986
FIT Exercise in 30d of ULLS-induced Muscle Disuse
Lance Bollinger
NCT06631053
Role of Metformin on Muscle Health of Older Adults
University of Utah
NCT03107884
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
Hospital for Special Surgery, New York
NCT03332238
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
Bijan Najafi, PhD
NCT06238609
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
University of Alabama at Birmingham
NCT04809714
Electrical Stimulation for Critically Ill Covid-19 Patients
Baylor College of Medicine
NCT04685213
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Muscle Atrophy Trial Landscape
ClinicalTrials.gov lists 12 US studies indexed under Muscle Atrophy, and 7 of those are currently open to recruitment — roughly 58% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Muscle Atrophy shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 5 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Muscle Atrophy is led by Tufts Medical Center with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Muscle Atrophy?
PlainTrial tracks 12 US clinical trials for Muscle Atrophy, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Muscle Atrophy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.